Stephens Inc Repligen Corp Transaction History

Stephens Inc

$7.43 Billion
Q3 2025

A detailed history of Stephens Inc transactions in Repligen Corp stock. As of the latest transaction made, Stephens Inc holds 48,838 shares of RGEN stock, worth $7.87 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

48,838

Previous 47,594 2.61%

Holding current value

$7.87 Million

Previous $5.92 Million 10.29%

% of portfolio

0.09%

Previous 0.09%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	BUY	$111.43 - $134.0 $138,618 - $166,696	1,244 Added 2.61%	48,838 $6.53 Million
Q2 2025 Jul 29, 2025	BUY	$108.89 - $145.23 $147,981 - $197,367	1,359 Added 2.94%	47,594 $5.92 Million
Q1 2025 May 01, 2025	SELL	$127.24 - $174.24 $70,109 - $96,006	-551 Reduced 1.18%	46,235 $5.88 Million
Q4 2024 Jan 28, 2025	BUY	$123.41 - $160.92 $10,613 - $13,839	86 Added 0.18%	46,786 $6.73 Million
Q3 2024 Oct 28, 2024	BUY	$119.79 - $167.35 $201,247 - $281,148	1,680 Added 3.73%	46,700 $6.95 Million
Q2 2024 Aug 06, 2024	BUY	$120.0 - $182.95 $545,640 - $831,873	4,547 Added 11.23%	45,020 $5.68 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $438,392 - $535,014	-2,567 Reduced 5.96%	40,473 $7.44 Million
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $59,025 - $95,825	-517 Reduced 1.19%	43,040 $7.74 Million
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $224,962 - $286,122	-1,621 Reduced 3.59%	43,557 $6.93 Million
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $266,735 - $347,457	1,927 Added 4.46%	45,178 $6.39 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $2.15 Million - $2.76 Million	-13,925 Reduced 24.35%	43,251 $7.28 Million
Q4 2022 Jan 25, 2023	BUY	$162.42 - $220.56 $536,635 - $728,730	3,304 Added 6.13%	57,176 $9.68 Million
Q3 2022 Nov 02, 2022	SELL	$160.42 - $256.21 $324,529 - $518,312	-2,023 Reduced 3.62%	53,872 $10.1 Million
Q2 2022 Aug 03, 2022	SELL	$140.68 - $188.02 $70,621 - $94,386	-502 Reduced 0.89%	55,895 $9.08 Million
Q1 2022 May 04, 2022	SELL	$161.19 - $257.96 $111,704 - $178,766	-693 Reduced 1.21%	56,397 $10.6 Million
Q4 2021 Mar 07, 2022	BUY	$247.59 - $304.47 $234,715 - $288,637	948 Added 1.69%	57,090 $15.1 Million
Q3 2021 Oct 27, 2021	SELL	$194.77 - $324.21 $498,805 - $830,301	-2,561 Reduced 4.36%	56,142 $16.2 Million
Q2 2021 Aug 12, 2021	SELL	$165.87 - $220.95 $39,642 - $52,807	-239 Reduced 0.41%	58,703 $11.7 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $403,848 - $506,596	2,239 Added 3.95%	58,942 $11.5 Million
Q4 2020 Feb 10, 2021	BUY	$148.08 - $206.57 $65,007 - $90,684	439 Added 0.78%	56,703 $10.9 Million
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $162,080 - $209,391	-1,323 Reduced 2.3%	56,264 $8.3 Million
Q2 2020 Aug 24, 2020	BUY	$94.33 - $140.48 $120,459 - $179,392	1,277 Added 2.27%	57,587 $7.12 Million
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $20,475 - $26,302	241 Added 0.43%	56,310 $5.44 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $156,983 - $197,888	-2,126 Reduced 3.65%	56,069 $5.19 Million
Q3 2019 Oct 18, 2019	BUY	$76.65 - $95.51 $255,244 - $318,048	3,330 Added 6.07%	58,195 $4.46 Million
Q2 2019 Aug 01, 2019	BUY	$54.2 - $85.95 $279,617 - $443,416	5,159 Added 10.38%	54,865 $4.72 Million
Q1 2019 May 03, 2019	BUY	$49.45 - $62.8 $3,065 - $3,893	62 Added 0.12%	49,706 $2.94 Million
Q4 2018 Feb 11, 2019	SELL	$48.26 - $68.88 $22,537 - $32,166	-467 Reduced 0.93%	49,644 $2.62 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $2.35 Million - $2.96 Million	50,111 New	50,111 $2.78 Million
Q3 2017 Nov 08, 2017	SELL	$36.98 - $46.06 $3.4 Million - $4.24 Million	-91,977 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	91,977	91,977 $3.81 Million

Others Institutions Holding RGEN

# of Institutions

511

Shares Held

59M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account